Pulmonary Hypoplasia
9
4
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
Milrinone in Congenital Diaphragmatic Hernia
Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia
Safety and Efficacy of FETO in CDH Phase III
Safety and Efficacy of FETO in CDH: A Phase III Trial
Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial
Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary Hypoplasia
Fetal Surgery for Moderate Left Sided Congenital Diaphragmatic Hernia.